These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32658921)

  • 41. Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study.
    Adewumi K; Nishimura H; Oketch SY; Adsul P; Huchko M
    J Cancer Educ; 2022 Aug; 37(4):1122-1128. PubMed ID: 33411253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
    Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
    BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
    Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
    BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
    Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
    BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program.
    Smith LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS
    BMC Public Health; 2014 Oct; 14():1060. PubMed ID: 25303975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    Mwenda V; Bor JP; Nyangasi M; Njeru J; Olwande S; Njiri P; Arbyn M; Weyers S; Tummers P; Temmerman M
    PLoS One; 2023; 18(5):e0286202. PubMed ID: 37228154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
    Shen J; Olwanda E; Kahn JG; Huchko MJ
    BMC Health Serv Res; 2018 May; 18(1):378. PubMed ID: 29801496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway.
    Burger EA; Pedersen K; Sy S; Kristiansen IS; Kim JJ
    Br J Cancer; 2017 Sep; 117(6):783-790. PubMed ID: 28772279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Saudi Women's Knowledge and Attitude toward Cervical Cancer Screening, Treatment, and Prevention: A Cross-Sectional Study in Qassim Region (2018-2019).
    Alnafisah RA; Alsuhaibani R; Alharbi MA; Alsohaibani AA; Ismail AA
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2965-2969. PubMed ID: 31653142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
    Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
    JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Peru cervical cancer prevention study (PERCAPS): community-based participatory research in Manchay, Peru.
    Levinson KL; Abuelo C; Chyung E; Salmeron J; Belinson SE; Sologuren CV; Ortiz CS; Vallejos MJ; Belinson JL
    Int J Gynecol Cancer; 2013 Jan; 23(1):141-7. PubMed ID: 23165314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
    Lee F; Bula A; Chapola J; Mapanje C; Phiri B; Kamtuwange N; Tsidya M; Tang J; Chinula L
    BMC Cancer; 2021 Apr; 21(1):428. PubMed ID: 33882885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A community-based, cross-sectional study of hrHPV DNA self-sampling-based cervical cancer screening in rural Karnataka, India.
    Adsul P; Srinivas V; Gowda S; Nayaka S; Pramathesh R; Chandrappa K; Khan A; Jayakrishna P; Madhivanan P
    Int J Gynaecol Obstet; 2019 Aug; 146(2):170-176. PubMed ID: 31074835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Peru Cervical Cancer Screening Study (PERCAPS): the design and implementation of a mother/daughter screen, treat, and vaccinate program in the Peruvian jungle.
    Abuelo CE; Levinson KL; Salmeron J; Sologuren CV; Fernandez MJ; Belinson JL
    J Community Health; 2014 Jun; 39(3):409-15. PubMed ID: 24276617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.